SUSTAINED EFFICACY OF BEDTIME INSULIN DAYTIME SULFONYLUREA (BIDS) FOR A SUBGROUP OF TYPE-II DIABETES

被引：0

作者：

HART, J ^{[1
]}

RIDDLE, M ^{[1
]}

机构：

[1] OREGON HLTH SCI UNIV,DEPT MED,PORTLAND,OR 97201

来源：

CLINICAL RESEARCH | 1988年 / 36卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页码：A153 / A153

页数：1

共 50 条

[1] AN EFFECTIVE NEW REGIMEN FOR TYPE-II DIABETES - BEDTIME INSULIN WITH DAYTIME SULFONYLUREA
RIDDLE, M
HART, J
BOUMA, D
PHILLIPSON, B
YOUKER, G
DIABETES, 1986, 35 : A66 - A66
[2] EFFICACY OF BEDTIME NPH INSULIN WITH DAYTIME SULFONYLUREA FOR SUBPOPULATION OF TYPE-II DIABETIC SUBJECTS
RIDDLE, MC
HART, JS
BOUMA, DJ
PHILLIPSON, BE
YOUKER, G
DIABETES CARE, 1989, 12 (09) : 623 - 629
[3] METABOLIC AND BEHAVIORAL-ASPECTS OF BEDTIME INSULIN DAYTIME SULFONYLUREA (BIDS)
PETERS, A
DAVIDSON, MB
DIABETES, 1993, 42 : A55 - A55
[4] SUPPERTIME MIXED INSULIN WITH DAYTIME SULFONYLUREA (SMIDS) FOR OBESE PERSONS WITH TYPE-II DIABETES
HART, J
RIDDLE, M
CLINICAL RESEARCH, 1990, 38 (01): : A121 - A121
[5] BEDTIME INSULIN PLUS DAYTIME ORAL SULFONYLUREA - EFFECTS ON BASAL AND POSTPRANDIAL GLUCOSE FLUXES IN TYPE-II DIABETICS
OSEI, K
HOLLAND, G
CLINICAL RESEARCH, 1986, 34 (04): : A909 - A909
[6] BEDTIME INSULIN ADDED TO DAYTIME SULFONYLUREAS IMPROVES GLYCEMIC CONTROL IN UNCONTROLLED TYPE-II DIABETES
MILLER, JL
SALMAN, K
SHULMAN, LH
ROSE, LI
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 53 (03) : 380 - 384
[7] TRIAL OF COMBINATION INSULIN SULFONYLUREA THERAPY FOR TYPE-II DIABETES - BEDTIME NPH INSULIN MORNING GLYBURIDE VERSUS INSULIN ALONE
RIDDLE, M
HART, J
BOUMA, D
PHILLIPSON, B
YOUKER, J
CLINICAL RESEARCH, 1986, 34 (01): : A64 - A64
[8] COMBINING INSULIN AND SULFONYLUREA - A THERAPEUTIC OPTION FOR TYPE-II DIABETES
RIDDLE, MC
POSTGRADUATE MEDICINE, 1992, 92 (02) : 89 - &
[9] EFFICACY OF COMBINED INSULIN-SULFONYLUREA IN THE TREATMENT OF TYPE-II DIABETES-MELLITUS - A METAANALYSIS
EHRENBERG, MA
CAPPUCCIO, JD
CLINICAL RESEARCH, 1990, 38 (02): : A693 - A693
[10] SULFONYLUREA-INSULIN THERAPY IN TYPE-II DIABETES-MELLITUS
SHABAN, HM
TORRE, MS
LIPKIN, FR
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1988, 22 (04): : 328 - 329

← 1 2 3 4 5 →